Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.
BTMD
Strong BuyUnloved QualityFLAGbiote Corp. · Healthcare · United States · $53M · Avg Vol: $410K/d
biote Corp. provides hormone-pellet therapy training and products to practitioners, and while quality and value screen well, the company has a nameable governance problem: a protracted public dispute with its founder over control and board composition, alongside a complex up-C share structure, on a roughly $64M market value. Momentum is weak (M40). No accounting failure is known, so this is a flag rather than a removal.
COMPANY DESCRIPTION
biote Corp. is a healthcare company specializing in preventive medicine and hormone optimization therapies through its proprietary training, software, and pellet products. The company's competitive moat is its extensive network of trained, certified practitioners and a highly scalable, recurring-revenue business model. Biote operates as a market leader in the specialized field of bioidentical hormone replacement therapy.
FINANCIAL SUMMARY (USD)
| Year | 2022 | 2023 | 2024 | 2025 | CAGR | TTM | 2026E | 2027E | Fwd CAGR |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 165.0M | 185.4M | 197.2M | 192.2M | 5.2% | 183.5M | 177.9M | 187.6M | -1.2% |
| EPS | -0.04 | 0.13 | 0.09 | 0.86 | 157.2% | 0.14 | 0.54 | 0.69 | -10.5% |
| Shares | 30.3M | 34.3M | 31.5M | 30.7M | +1.3% | 28.7M | — | — | — |
| Debt | 120.4M | 114.9M | 110.9M | 109.9M | -3.0% | 128.6M | — | — | — |
| Equity | -44.5M | -29.4M | -105.9M | -58.5M | — | — | — | — | — |
| Op CF | -9.2M | 26.9M | 45.2M | 35.2M | 14.4% | 24.4M | — | — | — |
| Inv CF | -1.8M | -2.7M | -18.8M | -6.9M | — | — | — | — | — |
| Fin CF | 63.5M | -14.4M | -76.1M | -43.6M | — | — | — | — | — |
SCORE BREAKDOWN
FUNDAMENTALS
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of BTMD are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| BTMD | biote Corp.(you) | $53M | 88 | Strong Buy |
| JYNT | The Joint Corp. | $119M | 84 | Strong Buy |
| CYH | Community Health Systems, Inc. | $413M | 73 | Buy |
| PARK | Park Dental Partners, Inc. | $99M | 39 | Hold |
| GMRS | GMR Solutions Inc. | $681M | 72 | Buy |
| ARDT | Ardent Health, Inc. | $1.5B | 88 | Strong Buy |
| WW | WW International, Inc. | $162M | 41 | Hold |
| DCGO | DocGo Inc. | $59M | 19 | Strong Sell |
| AMN | AMN Healthcare Services, Inc. | $1.3B | 96 | Strong Buy |
| HCSG | Healthcare Services Group, Inc. | $1.5B | 94 | Strong Buy |
Peer medians: ROE -30.1% · P/E 27.1x · Gross margin 57.9%